Format

Send to

Choose Destination
Clin Cancer Res. 2011 May 1;17(9):2608-12. doi: 10.1158/1078-0432.CCR-10-2770. Epub 2011 Mar 17.

New strategies in muscle-invasive bladder cancer: on the road to personalized medicine.

Author information

1
Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

Abstract

Bladder cancer remains one of the most deadly and expensive diseases affecting modern society. The options currently available to patients with muscle-invasive bladder cancer have remained essentially unchanged for the last generation. As the roles for surgery and chemotherapy in the management of this lethal disease have become better defined, so too have the limitations of these two treatment modalities. Despite the lack of groundbreaking clinical advances over the past two decades, recent years have witnessed a notable increase in the amount of promising preclinical and early translational research that will greatly improve our understanding of the molecular underpinnings of bladder cancer. If this momentum in bladder cancer research continues to build, it is likely that in the next 5 to 10 years we will be able to achieve our goal of bringing bladder cancer treatment into the age of personalized medicine.

PMID:
21415213
DOI:
10.1158/1078-0432.CCR-10-2770
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center